Peripheral Growth Balt is expanding beyond neurovascular into the peripheral vascular space, offering a broad portfolio for embolization in ischemic and hemorrhagic contexts. There is an opportunity to cross sell across neurovascular and peripheral devices, leverage existing physician partnerships, and establish regional distribution channels to accelerate adoption.

Innovation Rollout A recent Premarket Approval of a liquid embolic agent signals ongoing product innovation and regulatory progress. This creates opportunities to upsell new devices, provide clinician training and procedural support, and generate case studies with key hospitals to accelerate market adoption.

Capacity and Ops Balt has financing to expand production and accelerate product development, creating a need for manufacturing scale, quality systems, and resilient supply chains. Sales opportunities include offering manufacturing partnerships, equipment upgrades, and ancillary services that enable faster delivery of devices to hospitals and distributors.

Compliance Readiness The recent FCPA related disclosures and government declination highlight governance focusing on compliance. There is demand for anti bribery training, third party risk management, and audit readiness services to support international sales and distributor networks.

Physician Partnerships Balt follows a physician inspired and institution backed model. This approach can be leveraged to form registries, post market studies, training centers, and hands on workshops that drive adoption, clinician engagement, and long term partnerships with hospitals.